Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
Unions in Japan and the UK push for higher wages to combat rising living costs, reflecting global struggles to balance inflation and corporate profitability.
Williams acquires stakes in Woodside's Louisiana LNG project, investing $1.9B and leveraging its expertise in US natural gas infrastructure.
Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
Unions in Japan and the UK push for higher wages to combat rising living costs, reflecting global struggles to balance inflation and corporate profitability.
Williams acquires stakes in Woodside's Louisiana LNG project, investing $1.9B and leveraging its expertise in US natural gas infrastructure.